James E. Dentzer - 22 May 2026 Form 4 Insider Report for Imunon, Inc. (IMNN)

Source evidence 4 source fields
Form type
4
Accepted by SEC
27 May 2026, 16:13:06 UTC
Previous filing
23 Mar 2026
SEC filing
View on sec.gov
Reporting owner 1 detail
Reporting owner signature
/s/ Susan Eylward, Attorney-in-Fact for James E. Dentzer

Key filing fact

James E. Dentzer filed Form 4 for Imunon, Inc. (IMNN) on 27 May 2026.

Key facts

  • This page summarizes James E. Dentzer's Form 4 filing for Imunon, Inc. (IMNN).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 27 May 2026, 16:13.

Change

  • Previous filing in this sequence was filed on 23 Mar 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Reporting Owners (1)

CIK 0001400977 Primary reporting owner

Dentzer James E

Relationship
Director
Address
C/O IMUNON, INC., 997 LENOX DRIVE, SUITE 100, LAWRENCEVILLE
Signature
/s/ Susan Eylward, Attorney-in-Fact for James E. Dentzer
Signature date
27 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

IMNN transaction

Common Stock

Award

Transaction value
Shares
+11,148
Change %
+292%
Price
$2.20*
Shares after
14,963
Date
22 May 2026
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Stock granted in lieu of cash for portion of board fees

SEC remarks

On August 21, 2025, the Issuer paid a 15% stock dividend, 0.15 shares of common stock per share of the Issuer's issued and outstanding shares of common stock, to stockholders of record as of August 7, 2025. As a result of the stock dividend, the shares of Issuer Common Stock have been adjusted accordingly versus any amounts previously reported by the Reporting Person.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .